◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
TAKARA BIO INC. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 12, 2025Q4 2024Nov 11, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income 417.0M 1.4B -- -- -- --
Operating Margin % 76.0% 88.2% -- -- -- --
+Ordinary Income 549.0M 1.6B -- -- -- --
Revenue Growth % -65.6% -- -- -- -- --
Line ItemQ4 2025Nov 12, 2025Q4 2024Nov 11, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 57.7B 62.8B -- -- -- --
Total Assets 125.3B 121.3B 123.3B 111.5B 99.7B 83.8B
Current Liabilities 7.1B 7.2B -- -- -- --
Total Liabilities 9.5B 9.5B 11.2B 13.1B 19.1B 13.3B
Total Equity 115.8B 111.8B 112.1B 98.4B 80.6B 70.6B
Equity Ratio -- -- 0.91 0.88 0.81 0.84
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...